Hepatic steatosis and cardiovascular disease outcomes: An analysis of the Framingham Heart Study.
about
Nonalcoholic fatty liver disease as a multi-systemic diseaseNAFLD and Increased Aortic Stiffness: Parallel or Common Physiopathological Mechanisms?Endocrine causes of nonalcoholic fatty liver diseaseClinical advances in pediatric nonalcoholic fatty liver disease.Imaging methods for analyzing body composition in human obesity and cardiometabolic disease.Nonalcoholic Hepatic Steatosis Is a Strong Predictor of High-Risk Coronary-Artery Plaques as Determined by Multidetector CT.Higher association of coronary artery calcification with non-alcoholic fatty liver disease than with abdominal obesity in middle-aged Korean men: the Kangbuk Samsung Health StudyIncreased levels of low-density lipoprotein cholesterol within the normal range as a risk factor for nonalcoholic fatty liver disease.Insights from Genome-Wide Association Analyses of Nonalcoholic Fatty Liver Disease.The AST/ALT (De-Ritis) ratio: A novel marker for critical limb ischemia in peripheral arterial occlusive disease patients.The Framingham Heart Study--67 years of discovery in metabolic disease.Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease.Research update for articles published in EJCI in 2013.Nonalcoholic Fatty Liver Disease and Coronary Artery Calcification in a Northern Chinese Population: a Cross Sectional Study.Long-term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: A prospective cohort study.Bi-directional analysis between fatty liver and cardiovascular disease risk factors.Liver fat is related to cardiovascular risk factors and subclinical vascular disease: the Rotterdam Study.Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-Aged Adults in the Framingham Study.Digenic mutations on SCAP and AGXT2 predispose to premature myocardial infarction.Prognostic Value of Controlled Attenuation Parameter by Transient Elastography.Nonalcoholic Fatty Liver Disease Incidence and Impact on Metabolic Burden and Death: a 20 Year-Community Study.Relationship of hepatic steatosis severity and coronary artery disease characteristics assessed by coronary CT angiography.Managing the Burden of Non-NASH NAFLD.Nonalcoholic fatty liver disease contributes to subclinical atherosclerosis: A systematic review and meta-analysis.Non-alcoholic fatty liver disease is a strong predictor of coronary artery calcification in metabolically healthy subjects: A cross-sectional, population-based study in middle-aged subjects
P2860
Q26749290-3CD27140-02A8-4014-91FA-B838819985CAQ26750955-45FD2E6B-D72E-4B05-8882-4A2418284250Q26780254-EA45F32D-91C7-4D41-B1ED-2F99FF64D777Q30357622-26E53DF1-BF1F-4DCC-AAE2-36A7B04F439BQ30377639-A9D63B36-A99F-42DF-9746-3575879BC982Q35678746-44BF3ACA-C9A8-4026-A0C7-9B758E3601F3Q35848217-4DF3A1CA-68C0-438E-8E06-DA504A052085Q36905761-D5F79B3F-7ECF-4BAE-ADB4-71C5096CBA39Q37087800-04CA92BB-E5D5-4716-A390-0F0AF77E20E2Q37205618-61240082-0451-41E0-AD0C-5689FDACF833Q38699369-2E804FA3-911F-4EE9-9D34-10E0C2A0903FQ38711424-5340CD9E-33C8-43CC-9F83-1495B1E214BEQ38852737-AA64A4F3-B8F0-4A69-8B0C-EA7F9781EE71Q40064196-B7E8450F-ED85-490D-ABB1-3617ACD21F7EQ40501773-F32012D3-62CA-4B09-8F8C-CE410B3CB9F1Q40546061-F8015D69-53D4-439A-9639-29DB4ECD00FDQ40611707-E7648FBE-4214-473F-B590-E938CAB4A070Q46030301-F5CD3994-283A-4D99-B9A1-6ED50A85F325Q47104597-23231CE7-4255-4885-8D33-72B9C556FD4CQ47595041-64C97D90-17E4-40E1-9B6A-02857494A551Q47935385-6B640010-3B66-47D9-BEA8-DE001523D396Q52985248-F6A60BFE-EFFE-4027-B947-778639A2AEBBQ53704720-ADE330BF-33F5-4F05-BF6E-11A5687F12F2Q55180178-F40BA5F9-E98C-4314-B5DF-0CF915FCDE6EQ58722876-E10C19A8-578F-42B4-B79E-84570B589890
P2860
Hepatic steatosis and cardiovascular disease outcomes: An analysis of the Framingham Heart Study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 March 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatic steatosis and cardiova ...... of the Framingham Heart Study.
@en
Hepatic steatosis and cardiova ...... of the Framingham Heart Study.
@nl
type
label
Hepatic steatosis and cardiova ...... of the Framingham Heart Study.
@en
Hepatic steatosis and cardiova ...... of the Framingham Heart Study.
@nl
prefLabel
Hepatic steatosis and cardiova ...... of the Framingham Heart Study.
@en
Hepatic steatosis and cardiova ...... of the Framingham Heart Study.
@nl
P2093
P2860
P1476
Hepatic steatosis and cardiova ...... of the Framingham Heart Study.
@en
P2093
Caroline S Fox
Christopher J O'Donnell
Elizabeth K Speliotes
Jessica L Mellinger
Joseph M Massaro
Karol M Pencina
Udo Hoffmann
P2860
P304
P356
10.1016/J.JHEP.2015.02.045
P577
2015-03-14T00:00:00Z